Načítá se...
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
Circulating tumor DNA (ctDNA) offers new opportunities for noninvasive cancer management. Detecting ctDNA in plasma is challenging because it constitutes only a minor fraction of the total cell-free DNA (cfDNA). Pre-analytical factors affect cfDNA levels contributed from leukocyte lysis, hence the a...
Uloženo v:
| Vydáno v: | J Mol Diagn |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Investigative Pathology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6197164/ https://ncbi.nlm.nih.gov/pubmed/30165204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2018.07.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|